InvestorsHub Logo
Followers 1
Posts 22
Boards Moderated 0
Alias Born 01/05/2003

Re: ronpopeil post# 530

Saturday, 12/28/2019 9:43:15 PM

Saturday, December 28, 2019 9:43:15 PM

Post# of 1140
Interesting link ronpopeil. I think you are right that retail investors do not fully appreciate the importance of C1 and the glyco news. But I imagine big pharma does. I would like to see analysts get excited and start recommending this stock. I hope Mark is working on them diligently. Dyadic does not appear to have an dedicated investor relations person. This might then get retail investors bidding up the price and forcing big pharma to pay up more to ultimately take out Dyadic. This is my dream scenario. If this doesn't happen, I am afraid big pharma will still buy out Dyadic, but at a much lower price.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News